SBRT Combination With rhGM-CSF and Tα1 for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy

NCT02976740 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer Metastatic

Interventions

RADIATION: SBRT
DRUG: Immunological Agent
DRUG: Immunological Factors

Sponsor

The First Affiliated Hospital of Xiamen University